From €2302EUR$2,500USD£1,936GBP
- Report
- May 2024
- 279 Pages
Global
From €3222EUR$3,500USD£2,710GBP
€4603EUR$5,000USD£3,872GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3222EUR$3,500USD£2,710GBP
- Report
- April 2024
- 180 Pages
Global
From €4143EUR$4,500USD£3,485GBP
- Report
- March 2023
- 116 Pages
Global
From €4143EUR$4,500USD£3,485GBP
- Report
- December 2022
- 115 Pages
Global
From €4143EUR$4,500USD£3,485GBP
- Report
- January 2022
- 120 Pages
Global
From €4373EUR$4,750USD£3,678GBP
- Report
- March 2024
- 200 Pages
Global
From €3821EUR$4,150USD£3,214GBP
- Report
- February 2024
- 200 Pages
Global
From €6905EUR$7,500USD£5,808GBP
- Report
- April 2023
- 399 Pages
Global
From €8746EUR$9,500USD£7,357GBP
- Report
- January 2024
- 120 Pages
Global
From €7319EUR$7,950USD£6,157GBP
- Report
- May 2023
- 450 Pages
Global
From €4603EUR$5,000USD£3,872GBP
- Report
- January 2024
- 130 Pages
Global
From €4143EUR$4,500USD£3,485GBP
- Report
- May 2024
- 200 Pages
Global
From €3821EUR$4,150USD£3,214GBP
- Report
- May 2024
- 200 Pages
Global
From €3821EUR$4,150USD£3,214GBP
- Report
- May 2024
- 200 Pages
Global
From €3821EUR$4,150USD£3,214GBP
- Report
- July 2021
- 112 Pages
Global
From €4097EUR$4,450USD£3,446GBP
- Report
- December 2023
- 150 Pages
Global
From €4097EUR$4,450USD£3,446GBP
From €3176EUR$3,450USD£2,672GBP
- Report
- January 2022
- 176 Pages
Global
From €4097EUR$4,450USD£3,446GBP

CRISPR Therapeutics is a rapidly growing field within the genomics market. It is a gene-editing technology that uses a modified version of the CRISPR-Cas9 system to modify or replace genes in a living organism. This technology has the potential to revolutionize the way diseases are treated, as it can be used to target and modify specific genes that are responsible for certain diseases. It can also be used to create new treatments for diseases that have no existing treatments.
CRISPR Therapeutics has been used to develop treatments for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. It has also been used to create new treatments for rare diseases, as well as to develop new therapies for existing diseases.
Companies in the CRISPR Therapeutics market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences. These companies are working to develop treatments for a variety of diseases, as well as to create new therapies for existing diseases. Show Less Read more